The global long-read metagenomics market is poised for substantial growth, driven by advancements in sequencing technologies and increased interest in microbiome research. According to a recent report added to ResearchAndMarkets.com’s offerings, the market is projected to expand from $1.79 billion in 2025 to $2.16 billion in 2026, marking a compound annual growth rate (CAGR) of 21.1%.
Several factors have historically contributed to this growth, including the reduction in DNA sequencing costs, the proliferation of next-generation sequencing platforms, and heightened investments in genomic research. Additionally, the development of metagenomic assembly tools and a growing interest in microbiome analysis have further fueled the adoption of long-read sequencing in various fields such as research, healthcare, and environmental applications.
Looking forward, the market is expected to reach $4.69 billion by 2030, with a CAGR of 21.3%. Key drivers of this growth include the adoption of precision medicine, the expansion of clinical metagenomics diagnostics, and the increasing use of real-time pathogen monitoring systems. The demand for portable sequencing solutions is also on the rise. The integration of artificial intelligence into genomic analytics is anticipated to enhance data interpretation, workflow efficiency, and sequencing accuracy.
Notable trends in the long-read metagenomics market include high-resolution microbial strain identification, advanced error-correction and sequence-polishing algorithms, and real-time pathogen surveillance using environmental DNA. Ultra-deep metagenomic profiling for detecting rare species is also gaining traction. Improvements in sample preparation and high-molecular-weight DNA extraction are enhancing the quality and reliability of long-read sequencing results.
The growing burden of infectious diseases is a significant factor driving market expansion. The emergence of antimicrobial-resistant pathogens and the increasing frequency of disease outbreaks necessitate faster and more accurate pathogen detection methods. Long-read metagenomics facilitates the identification of pathogens, antimicrobial resistance genes, and genomic variations in complex clinical and environmental samples, thereby strengthening disease surveillance and improving epidemiological monitoring across healthcare and public health systems.
In October 2024, the World Health Organization reported that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from 7.5 million in 2022. This increase underscores the ongoing need for advanced genomic surveillance technologies to support outbreak response, clinical research, and infectious disease management.
Technology providers are responding to these needs by introducing high-throughput sequencing and genomic analysis solutions designed to automate workflows, improve variant detection, and reduce bioinformatics costs. For instance, in February 2024, Pacific Biosciences launched the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for its Revio sequencing system. These library preparation solutions enable automated sample preparation, greater scalability, shorter workflow times, and lower sequencing costs. HiFi long-read sequencing also supports complex metagenome assembly and detailed microbial community analysis.
Strategic partnerships are further advancing long-read sequencing applications. In July 2024, Oxford Nanopore Technologies partnered with Plasmidsaurus to expand the use of nanopore-based long-read sequencing in microbial genomics, plasmid analysis, and metagenomic workflows. This collaboration aims to enhance sequencing accuracy, improve scalability, strengthen microbial genome assembly, and accelerate the characterization of complex microbial communities for both research and clinical applications.
Geographically, North America led the long-read metagenomics market in 2025, reflecting the region’s established genomic research infrastructure, technology adoption, and investment in precision medicine. The Asia-Pacific region is expected to experience rapid growth during the forecast period. The market analysis encompasses various regions, including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries analyzed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
The report categorizes the market by sequencing technology type, sample type, technology modality type, and end-user type, providing a comprehensive overview of the market landscape. Companies featured in the report include Illumina Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., and others.
Footnotes:
- The global long-read metagenomics market is projected to grow from $1.79 billion in 2025 to $2.16 billion in 2026. Source.
- The market is expected to reach $4.69 billion by 2030, with a CAGR of 21.3%. Source.
- In October 2024, the World Health Organization reported an increase in tuberculosis diagnoses from 7.5 million in 2022 to 8.2 million in 2023. Source.
Featured Image: Megapixl @ Convisum